FBT
CELG

First Bank & Trust’s Celgene Corp CELG Stock Holding History

First Bank & Trust’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,961
Closed -$294K – 419
2019
Q3 		$294K Buy
2,961
+76
+3% +$7.22K 0.22% 101
2019
Q2 		$266K Sell
2,885
-284
-9% -$27K 0.21% 107
2019
Q1 		$299K Buy
3,169
+217
+7% +$19K 0.23% 108
2018
Q4 		$189K Sell
2,952
-242
-8% -$17.9K 0.16% 133
2018
Q3 		$302K Buy
3,194
+103
+3% +$9.1K 0.23% 112
2018
Q2 		$246K Sell
3,091
-154
-5% -$12.8K 0.19% 126
2018
Q1 		$290K Sell
3,245
-90
-3% -$8.64K 0.23% 108
2017
Q4 		$348K Sell
3,335
-15
-0.4% -$1.69K 0.27% 96
2017
Q3 		$488K Sell
3,350
-34
-1% -$4.63K 0.4% 72
2017
Q2 		$440K Buy
3,384
+405
+14% +$49.6K 0.37% 76
2017
Q1 		$370K Sell
2,979
-22
-0.7% -$2.63K 0.32% 83
2016
Q4 		$347K Buy
+3,001
New +$334K 0.32% 87

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

First Bank & Trust's CELG Position: Q4 2019 in Review

First Bank & Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,961 shares — an estimated $294K sold.

First Bank & Trust first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $488K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • First Bank & Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • First Bank & Trust sold 2,961 Celgene Corp shares in Q4 2019, an estimated $294K.
  • First Bank & Trust first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • First Bank & Trust's Celgene Corp position peaked at $488K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on First Bank & Trust's 13F filing for Q4 2019, filed 31 Jan 2020.